M85.09 Fibrous dysplasia (monostotic), multiple sites

Name of the Condition

• Fibrous Dysplasia (Monostotic), Multiple Sites (ICD-10 Code: M85.09)
• A benign bone disorder characterized by abnormal fibrous tissue replacing normal bone, affecting multiple sites in the skeleton.

Summary

Fibrous dysplasia (monostotic), multiple sites, is a condition where fibrous tissue abnormally replaces normal bone in more than one area of the skeleton. This can weaken bone structure, potentially leading to deformity or fracture. The term "multiple sites" indicates involvement of several bones, distinguishing it from monostotic forms affecting a single bone.

Causes

The exact cause is unknown, but it involves a genetic mutation affecting bone-forming cells. The mutation leads to abnormal development of bone tissue, resulting in a mix of fibrous and osseous material. It is not typically inherited.

Risk Factors

• Age: Most commonly diagnosed in children and young adults.
• Gender: Slightly more prevalent in females.
• No known environmental or lifestyle risk factors have been identified.

Symptoms

• Bone pain or aching, often worsening with activity.
• Swelling or deformity in the affected areas.
• Increased risk of fractures from minor trauma.
• Asymptomatic in some cases, discovered incidentally on imaging.

Diagnosis

Diagnosis is based on clinical evaluation, imaging, and sometimes biopsy. X-rays or CT scans show characteristic "ground-glass" appearance of affected bone. MRI may be used to assess soft tissue involvement. Biopsy confirms fibrous tissue replacement of bone.

Treatment Options

• Monitoring: For asymptomatic cases, regular imaging may suffice.
• Pain management: NSAIDs or other analgesics for discomfort.
• Surgical intervention: For deformity, fractures, or functional impairment, procedures like bone grafting or corrective osteotomy may be considered.
• Medications: Bisphosphonates to reduce bone pain and risk of fracture in some cases.

Prognosis and Follow-Up

Prognosis is generally good, as the condition is non-cancerous. However, complications like fractures or deformity may require ongoing management. Follow-up with imaging and clinical evaluation is recommended to monitor for changes.

Complications

• Pathologic fractures due to weakened bone.
• Bone deformity affecting function or appearance.
• Rarely, malignant transformation (osteosarcoma) in long-standing cases.

Lifestyle & Prevention

• Avoid high-impact activities to reduce fracture risk.
• Maintain bone health with adequate calcium and vitamin D intake.
• Regular physical activity to support overall skeletal strength, avoiding excessive strain on affected areas.

When to Seek Professional Help

Seek medical attention if experiencing persistent bone pain, swelling, or deformity, or if a fracture occurs. Prompt evaluation is important to assess severity and guide treatment.

Tips for Medical Coders

Document the specific sites affected to support the "multiple sites" designation. Ensure clinical notes align with the diagnosis, as this code requires confirmation of fibrous dysplasia involving more than one bone. Avoid using this code for monostotic (single-site) cases.